- Overview
- Bayer Group
- Stock
- Bonds
- Reports
- Annual Stockholders’ Meeting 2019
- Events
- Inside Information
- News
- Investor News
- Press
- Archive
- Overview
- Investor News 2018
- Investor News 2017
- Investor News 2016
- Investor News 2015
- Investor News 2014
- Investor News 2013
- Investor News 2012
- Investor News 2011
- Investor News 2010
- Investor News 2009
- Investor News 2008
- Investor News 2007
- Investor News 2006
- Investor News 2005
- Investor News 2004
- Investor News 2003
- Investor News 2002
- Investor News 2001
- Investor News 2000
- Handouts
- Downloads
- Service
Q1 2018 Investor Conference Call
Thursday, May 3, 2018
Start at approx. 2:00 p.m. CEST (12:00 noon UTC)
First quarter of 2018
Bayer: Operational business held back by currency effects - Major progress with Monsanto acquisition
Group sales increase by 2.0 percent (Fx & portfolio adj.) to 9.138 billion euros / EBITDA before special items down year on year at 2.896 billion euros due to currency effects - level with prior-year quarter on a currency-adjusted basis / Sales increase at Pharmaceuticals (Fx & portfolio adj.) / Consumer Health down year on year, as expected / Sales of Crop Science match strong prior-year quarter (Fx & portfolio adj.) / Animal Health raises sales (Fx & portfolio adj.) and earnings / Net income declines by 6.2 percent to 1.954 billion euros / Core earnings per share down 1.3 percent at 2.28 euros / European Commission and additional regulators conditionally approve Monsanto acquisition / Currency adjusted Group outlook for 2018 confirmed moreOn-demand audio recording of the presentation and discussion
(including slides)
Audio recording of the presentation and discussion
(MP3 format)
You can also play the audio recording on your mobile device.
Presentation charts | Download PDF collect (929 KB) |
Interim Report First Quarter 2018 | Online version Download PDF collect (391 KB) |
Q1 2018 Analyst and Investor Briefing | Download PDF collect (370 KB) |
Transcript | Download PDF collect (109 KB) |
Q1 2018 All in One Package for Investors and Analysts All documents in one ZIP file | Download ZIP collect (2 MB) |